The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
Introduction: Endometrioid endometrial carcinoma (EEC) is the most common type of endometrial cancer, accounting for approximately 80-90% of all endometrial cancer cases. Endometrial hyperplasia deserves special attention because of its relationship with endometrialcinoma. This study's goal was...
Saved in:
| Main Authors: | Sudha M, Shanmugapriya M, Vijay A |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KIMS Foundation and Research Center
2025-06-01
|
| Series: | Journal of Medical and Scientific Research |
| Subjects: | |
| Online Access: | https://jmsronline.com/archive-article/cyclin-D1-endometrial-hyperplasia-carcinoma |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern approaches to the diagnosis of endometrial hyperplasia
by: M. M. Damirov, et al.
Published: (2025-02-01) -
Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014-07-01) -
Expression of Cyclin D1 in Hyperplastic and Neoplastic Endometrial Lesions
by: Summayya Shawana, et al.
Published: (2017-03-01) -
Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024-07-01) -
Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
by: An-Ju Chou, et al.
Published: (2024-11-01)